BEAM – beam therapeutics inc. (US:NASDAQ)

News

Bernstein Maintains an Outperform Rating on Beam Therapeutics Inc. (BEAM) [Yahoo! Finance]
Cathie Wood quietly buys $7.27 million of popular tech stock [Yahoo! Finance]
Beam Therapeutics (NASDAQ:BEAM) was given a new $41.00 price target on by analysts at Tudor Pickering.
Beam Therapeutics (NASDAQ:BEAM) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Beam Therapeutics: Pivoting From Platform To Execution Stage [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com